Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rusoma Laboratories is a prominent Indian pharmaceutical company focused on the production of sterile intravenous (IV) fluids and parenteral preparations. Established in 1970 and headquartered in Indore, the company employs advanced Blow-Fill-Seal (BFS) technology to ensure high-quality, aseptic manufacturing of its products. Its portfolio includes a variety of electrolyte solutions, carbohydrates, osmotic diuretics, and anti-infective agents such as Ciprofloxacin and Metronidazole. Rusoma caters to a broad range of healthcare needs in critical care and fluid management, serving both the Indian domestic market and various international regions. The company is recognized for its large-scale production capacity and adherence to Good Manufacturing Practices (GMP). As a key player in the infusion therapy segment, Rusoma provides essential medical supplies to hospitals and healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rusoma.